Vetter’s European clinical site receives permanent Manufacturer’s Authorization
Ongoing investments in the supply chain for complex injectable medications
Identified as best-in-class CDMO in global biopharmaceutical aseptic fill-and-finish services
We just published our annual sustainability report.
Vetter honored as an exceptionally managed company.
Vetter further expands offerings for clinical development and manufacturing.
Vetter honored as winner in all six core award categories.
Vetter strengthens worldwide commitment to sustainable business practices
Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development
Vetter significantly increases its sustainability rating.
Vetter’s SVP Key Account Management, Supply Chain Management (SCM), & Marketing reflects on a volatile year and looks ahead to 2023.